|Institutional Source||Beutler Lab|
|Gene Name||ring finger protein 213|
|Is this an essential gene?||Non essential (E-score: 0.000)|
|Stock #||R7026 (G1)|
|Chromosomal Location||119393100-119487418 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to C at 119479655 bp (GRCm38)|
|Amino Acid Change||Histidine to Proline at position 4760 (H4760P)|
|Ref Sequence||ENSEMBL: ENSMUSP00000115063 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000093902] [ENSMUST00000131035] [ENSMUST00000172235]|
|AlphaFold||no structure available at present|
AA Change: H4761P
AA Change: H4760P
PolyPhen 2 Score 0.582 (Sensitivity: 0.88; Specificity: 0.91)
AA Change: H4760P
|Meta Mutation Damage Score||0.1795|
|Coding Region Coverage||
|Validation Efficiency||99% (69/70)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries. This gene is also a translocation partner in anaplastic large cell lymphoma and inflammatory myofibroblastic tumor cases, where a t(2;17)(p23;q25) translocation has been identified with the anaplastic lymphoma kinase (ALK) gene on chromosome 2, and a t(8;17)(q24;q25) translocation has been identified with the MYC gene on chromosome 8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2011]
PHENOTYPE: Mice homozygous for a knock-out allele exhibit decreased body weight and circulating glucose level but normal glucose tolerance, insulin sensitivity, insulin plasma levels and leptin plasma levels. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Rnf213||
(F):5'- AGCAGACTCACTCAGCAGTATC -3'
(R):5'- ATACAGCCATGTTCCGACTC -3'
(F):5'- GACTCACTCAGCAGTATCAATCC -3'
(R):5'- GCCATGTTCCGACTCATAGCAG -3'